UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

Annals of oncology, 2014-06, Vol.25 (6), p.1128-1136

2014

Link zum Volltext

Verfügbarkeit prüfen

PALB2, a major susceptibility gene for breast cancer

Gynécologie, obstétrique, fertilité & sénologie, 2018-11, Vol.46 (10-11), p.701-705

2018

Link zum Volltext

Verfügbarkeit prüfen

Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

Familial cancer, 2018, Vol.17 (1), p.5-14

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer

Pain (Amsterdam), 2017-06, Vol.158 (6), p.1118-1125

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

Annals of oncology, 2006-01, Vol.17 (1), p.85-92

2006

Link zum Volltext

Verfügbarkeit prüfen

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

Genetics in medicine, 2010-12, Vol.12 (12), p.801-807

2010

Link zum Volltext

Verfügbarkeit prüfen

French version of FACT-G: validation and comparison with other cancer-specific instruments

European journal of cancer (1990), 2004-10, Vol.40 (15), p.2243-2252

2004

Link zum Volltext

Verfügbarkeit prüfen

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study

Annals of oncology, 2001-03, Vol.12 (3), p.397-404

2001

Link zum Volltext

Verfügbarkeit prüfen

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing

Familial cancer, 2012-06, Vol.11 (2), p.269-278

2012

Link zum Volltext

Verfügbarkeit prüfen

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

Annals of oncology, 2006-01, Vol.17 (1), p.65-73

2006

Link zum Volltext

Verfügbarkeit prüfen

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3115-3124

the French Epirubicin Study Group

2000

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009–2010: The AnemOnHe study

European journal of cancer (1990), 2012-01, Vol.48 (1), p.101-107

2012

Link zum Volltext

Verfügbarkeit prüfen

Mutation analysis of PALB2 gene in French breast cancer families

Breast cancer research and treatment, 2015-12, Vol.154 (3), p.463-471

2015

Link zum Volltext

Verfügbarkeit prüfen

The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation

International journal of radiation oncology, biology, physics, 1994-07, Vol.29 (4), p.673-679

1994

Link zum Volltext

Verfügbarkeit prüfen

Quality of life in long-term survivors of oropharynx carcinoma

International journal of radiation oncology, biology, physics, 2002-11, Vol.54 (3), p.742-751

2002

Link zum Volltext

Verfügbarkeit prüfen

Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality

International journal of epidemiology, 2000-04, Vol.29 (2), p.214-223

2000

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study

Gynecologic oncology, 1999-11, Vol.75 (2), p.187-193

1999

Link zum Volltext

Verfügbarkeit prüfen

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity

International journal of radiation oncology, biology, physics, 2004-11, Vol.60 (4), p.1056-1065

2004

Link zum Volltext

Verfügbarkeit prüfen

Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer

International journal of radiation oncology, biology, physics, 1998-12, Vol.42 (5), p.935-941

1998

Link zum Volltext

Verfügbarkeit prüfen

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

European journal of cancer (1990), 2001-06, Vol.37 (9), p.1132-1140

2001

Link zum Volltext

Verfügbarkeit prüfen

Epidermoid carcinomas of the floor of mouth treated by exclusive irradiation: statistical study of a series of 207 cases

Radiotherapy and oncology, 1995-06, Vol.35 (3), p.177-185

1995

Link zum Volltext

Verfügbarkeit prüfen

Combined surgery and brachytherapy in the treatment of some cancers of the bladder (partial cystectomy and interstitial iridium-192)

Radiotherapy and oncology, 1996-02, Vol.38 (2), p.115-120

1996

Link zum Volltext

Verfügbarkeit prüfen

The effects of interaction between familial and reproductive factors on breast cancer risk: a combined analysis of seven case-control studies

British journal of cancer, 1998-05, Vol.77 (9), p.1525-1536

1998

Link zum Volltext

Verfügbarkeit prüfen

Familial risk, abortion and their interactive effect on the risk of breast cancer - a combined analysis of six case-control studies

British journal of cancer, 1995-09, Vol.72 (3), p.744-751

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 59

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(59)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(59)
Female
(56)
Aged
(47)
Adult
(46)
Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Oncology
(38)
Male
(30)
Aged, 80 And Over
(28)
Biological And Medical Sciences
(27)
Medical Sciences
(27)
Retrospective Studies
(23)
Prognosis
(19)
Radiology, Nuclear Medicine & Medical Imaging
(19)
Survival Analysis
(16)
Radiotherapy Dosage
(15)
Breast Cancer
(14)
Carcinoma, Squamous Cell - Radiotherapy
(13)
Tumors
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

PALB2, a major susceptibility gene for breast cancer

Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

French version of FACT-G: validation and comparison with other cancer-specific instruments

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009–2010: The AnemOnHe study

Mutation analysis of PALB2 gene in French breast cancer families

The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation

Quality of life in long-term survivors of oropharynx carcinoma

Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality

A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity

Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

Randomized Trial Comparing Six Versus Three Cycles of Epirubicin-Based Adjuvant Chemotherapy in Premenopausal, Node-Positive Breast Cancer Patients: 10-Year Follow-Up Results of the French Adjuvant Study Group 01 Trial

Epidermoid carcinomas of the floor of mouth treated by exclusive irradiation: statistical study of a series of 207 cases

Combined surgery and brachytherapy in the treatment of some cancers of the bladder (partial cystectomy and interstitial iridium-192)

The effects of interaction between familial and reproductive factors on breast cancer risk: a combined analysis of seven case-control studies

Familial risk, abortion and their interactive effect on the risk of breast cancer - a combined analysis of six case-control studies

Aktive Filter

Suchergebnisse filtern